Statsols Nquery

Statsols is the company behind nQuery. nQuery is the complete trial design platform to make clinical trials faster, less costly and more successful. For over 20 years, we have worked with biostatisticians and researchers all over the world to ensure they meet their regulatory requirements and make clinical trials as efficient and ethical as possible. nQuery covers all phases (I - IV) and all types of trial designs (classical to adaptive). In 2021, 88% of organizations with FDA approved clinical trials used nQuery for their study designs. In 2022, Statsols became part of Dotmatics. Dotmatics is a leader in R&D scientific software connecting science, data, and decision-making. Its enterprise R&D platform and scientists’ favorite applications drive efficiency and accelerate innovation. More than 2 million scientists and customers trust Dotmatics to help them create a healthier, cleaner, safer world. Dotmatics is backed by Insight Partners, a leading global venture capital and private equity firm investing in high-growth technology and software scaleup companies.**nQuery in Numbers** We have customers in over 100 countries Over registered software users 45 of top 50 Pharma companies are Statsols customers In 2021, 88% of organizations with FDA approved clinical trials used nQuery for their study designs.